Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Författare
Summary, in English
To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast cancer (CBC) risk for BRCA1 and/or BRCA2 mutation carriers.
Avdelning/ar
- Bröstcancer-genetik
- EpiHealth: Epidemiology for Health
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2013
Språk
Engelska
Sidor
3091-3091
Publikation/Tidskrift/Serie
Journal of Clinical Oncology
Volym
31
Issue
25
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
American Society of Clinical Oncology
Ämne
- Cancer and Oncology
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1527-7755